Evotec achieves clinical development milestone as part of its multi-target alliance with Bayer
Evotec AG announced that it has reached a milestone from Bayer for the progression of a programme from the alliance portfolio into Phase I clinical development for the treatment of endometriosis, triggering a milestone payment to Evotec.
This milestone was achieved under the strategic allia ... more
Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines
Bayer and X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, have entered into an expanded global drug discovery collaboration across multiple therapeutic areas and targe ... more
Bayer posts strong earnings growth
The Bayer Group made further strategic progress and posted strong earnings growth in the third quarter of 2015. “A few weeks ago we announced changes to our organizational structure. The new organization is aimed at supporting our strategy as a leading Life Science company and putting us in ... more